Comparison of Cardiac Index and Stroke-volume-index Measured by Pulmonary Artery Catheter, FloTrac® and Argos® in Cardiac Surgery Patients.
NCT ID: NCT06918301
Last Updated: 2025-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2025-03-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Pulmonary artery catheter
2. Flo Trac
3. Argos Monitor Investigations will be done in theater and on ICU in ventilated and spontaneously breathing patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparability of Transesophageal Echocardiography and FloTrac/Vigileo System Three Different Positions
NCT05508711
Evaluation of a Non-invasive Cardiac Output Monitoring System.
NCT03178162
Evaluation of a Non-invasive Cardiac Output Monitoring System.
NCT03178097
A Comparison of Thoracic Electrical Bioimpedance and FloTrac/Vigileo
NCT06143111
Using Pulse Counter Vigileo-Flotrac System in Transapical Off-pump Minimally Invasive Mitral Valve Repair
NCT03506217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurement of cardiac performance
Measurement of cardiac performance by different devices
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karlsburg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Matthias Heringlake
Head of department of anesthesiology and intensive care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Heringlake
Role: PRINCIPAL_INVESTIGATOR
Head of Department of Anesthesiology and intensive care, Karlsburg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Anästhesiologie und Intensivmedizin, Klinikum Karlsburg
Karlsburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Matthias Heringlake
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAIKB 2025-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.